OMADA HEALTH ($OMDA) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of $0.01 per share, beating estimates of -$0.08 by $0.09. The company also reported revenue of $78,050,000, beating estimates of $75,516,995 by $2,533,005.
Stock price change since market close: +9.15%
You can see Quiver Quantitative's $OMDA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
OMADA HEALTH Insider Trading Activity
OMADA HEALTH insiders have traded $OMDA stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $OMDA stock by insiders over the last 6 months:
- SEAN P. DUFFY (Chief Executive Officer) has made 0 purchases and 6 sales selling 284,604 shares for an estimated $4,446,580.
- WEI-LI SHAO (President) has made 0 purchases and 2 sales selling 8,447 shares for an estimated $126,591.
- STEVEN L. COOK (Chief Financial Officer) has made 0 purchases and 2 sales selling 6,095 shares for an estimated $90,967.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
OMADA HEALTH Hedge Fund Activity
We have seen 95 institutional investors add shares of OMADA HEALTH stock to their portfolio, and 40 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- REVELATION CAPITAL MANAGEMENT, LLC added 5,208,034 shares (+inf%) to their portfolio in Q4 2025, for an estimated $82,182,776
- MILLENNIUM MANAGEMENT LLC added 2,096,705 shares (+1195.0%) to their portfolio in Q4 2025, for an estimated $33,086,004
- CITADEL ADVISORS LLC added 1,245,277 shares (+5330.1%) to their portfolio in Q4 2025, for an estimated $19,650,471
- A16Z CAPITAL MANAGEMENT, L.L.C. removed 1,153,645 shares (-25.0%) from their portfolio in Q4 2025, for an estimated $18,204,518
- JEFFERIES FINANCIAL GROUP INC. added 1,073,991 shares (+inf%) to their portfolio in Q4 2025, for an estimated $16,947,577
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 910,344 shares (-66.0%) from their portfolio in Q4 2025, for an estimated $14,365,228
- SG AMERICAS SECURITIES, LLC added 827,447 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,401,008
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
OMADA HEALTH Analyst Ratings
Wall Street analysts have issued reports on $OMDA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/05/2026
- BMO Capital issued a "Outperform" rating on 11/13/2025
To track analyst ratings and price targets for OMADA HEALTH, check out Quiver Quantitative's $OMDA forecast page.
OMADA HEALTH Price Targets
Multiple analysts have issued price targets for $OMDA recently. We have seen 10 analysts offer price targets for $OMDA in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Constantine Davides from Citizens set a target price of $18.0 on 04/14/2026
- David Roman from Goldman Sachs set a target price of $23.0 on 04/09/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $15.0 on 04/08/2026
- Destiny Jackson from JP Morgan set a target price of $26.0 on 03/12/2026
- Craig Hettenbach from Morgan Stanley set a target price of $30.0 on 03/06/2026
- Saket Kalia from Barclays set a target price of $18.0 on 03/06/2026
- Sean Dodge from BMO Capital set a target price of $18.0 on 03/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
